Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Sterling Biotech Money...

    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-08-11T09:47:49+05:30  |  Updated On 11 Aug 2019 9:47 AM IST
    Sterling Biotech Money Laundering Case: Relief to co-accused as Delhi HC junks ED plea to cancel bail

    Justice Sunil Gaur said the accused deserve bail on merits and the orders granting them relief is not liable to be interfered with as the impugned orders do not suffer from any infirmity or illegality.


    NEW DELHI: The Delhi High Court has dismissed the Enforcement Directorate's (ED) pleas seeking cancellation of bail to a businessman and a co-accused in the over Rs 8,000-crore money laundering case involving Gujarat-based Sterling Biotech Ltd.


    ED had challenged two separate orders of the trial court granting bail to Delhi-based businessman Gagan Dhawan and another accused Ranjit Malik alias Johny -- who was earlier arrested by the agency for allegedly sending through a man, Rakesh Chandra, Rs 25 lakh to a prominent senior Congress leader's residence in the national capital.


    Justice Sunil Gaur said the accused deserve bail on merits and the orders granting them relief is not liable to be interfered with as the impugned orders do not suffer from any infirmity or illegality.


    "There is no basis for this court to conclude that the court below has erroneously exercised its discretion in granting bail to respondents - accused persons or that the exercise of discretion in granting bail to respondents - accused persons is arbitrary," the high court.


    It dismissed the petitions, making it clear that any observation made will have no bearing on merits at the trial.


    The ED has alleged that Dhawan had facilitated the directors of Gujarat-based pharma firm Sterling Biotech Ltd (SBL) in the purchase of several properties and helped in misuse and diversion of credit facilities of several bank totalling over Rs 8,000 crore.


    ED challenged the trial court's orders granting bail to Dhawan and Malik on the ground that they disclose utter non-application of mind and that gravity of offence has not been considered.


    The counsel for the two accused opposed the stand taken by the agency and submitted that the gravity of offence cannot be the sole consideration for grant or refusal of bail.


    The high court, in its order, said: "It is settled the position of law that the parameters for cancellation of bail and the grounds for challenging the order of grant of bail on the ground of arbitrary exercise of discretion are altogether different. In matters of a grant of bail, the merits of the case are not required to be gone into in detail."


    "The court below in the impugned orders has taken note of the gist of the offence alleged against respondent-accused persons and has thereafter, taken into consideration the fact that the final report had been filed," it said.


    It said that in case of Dhawan, the extent of money laundering alleged is of Rs 1.5 crore and said noted that during the investigation, attachment of the accused' property to the extent of Rs 1.17 crore has already taken place and a supplementary complaint has already been filed and the case is at the stage of framing charges.


    So far, the agency has charge-sheeted 191 accused, including seven individuals and 184 companies.


    The court had earlier issued open-ended non-bailable warrants against pharma firm's directors, including Nitin Jayantilal Sandesara, Chetan Jayantilal Sandesara and his wife Dipti Chetan Sandesara.


    The accused included main promoters of Sterling Group -- Sandesaras, Rajbhushan Dixit, Hitesn Patel, Chartered Accountant Hemant Hathi and middleman Gagan Dhawan.


    The companies include Sterling Biotech Ltd, PMT Machines Ltd, Sterling SEZ and Infra Ltd, Sterling Port Ltd, Sterling Oil Resources Ltd and 179 shell companies.


    The charge sheet has said that the accused manipulated figures in the balance sheets of their flagship companies and induced banks to sanction higher loans.


    "After obtaining loans, they diverted the loans funds to non-mandated purposes through a web of shell companies.


    "Thus, the loan funds were diverted, layered and laundered by the promoters for their personal purposes. A total amount of loan fraud as on date is Rs 8,100 crore. The loan frauds pertain to domestic as well as offshore branches of Indian Banks," it has said.


    Besides Dhawan and Malik, the ED had earlier arrested a former director of Andhra Bank, Anup Prakash Garg in the case. He is out on bail.


    Read Also: Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel

    Chetan Jayantilal SandesaraDelhi high courtEDED pleaEnforcement DirectorateGagan Dhawangranting bailmoney laundering caseNitin Jayantilal Sandesarapharmapharma newspharma news indiaPMT Machines LtdRakesh ChandraRanjit Malik alias JohnySandesarasSterling BiotechSunil Gaur
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok